Press Releases

CluePoints Data and Knowledge Manager Appointed to ACT Editorial Advisory Board

CluePoints, provider of leading statistical and AI-driven software solutions, has announced Sylviane de Viron, its Data and Knowledge Manager, has been appointed to the Applied Clinical Trials (ACT) editorial advisory board.

Abselion Launches His-tagged Protein Quantification Kit and Sensors for Amperia at PEGS Europe 2025

• Ready-to-use solution, developed in collaboration with GenScript, offers rapid and reliable quantification of His-tagged proteins • Broadens Amperia’s applications across recombinant protein research, screening, and development • Abselion to showcase kit alongside Amperia platform at PEGS Europe in Lisbon, Portugal from 11–13 November

Baylor Genetics Launches Pharmacogenomic and Germline Genetic Testing for the U.S. Department of Veterans Affairs

Baylor Genetics, a clinical diagnostic laboratory at the forefront of genetic testing, today announced it was awarded a multi-year national contract from the United States Department of Veterans Affairs (VA) to deliver pharmacogenomic (PGx) testing and germline genetic testing services, which includes hereditary cancer testing to veterans across the VA healthcare system.

Baylor Genetics Applauds Medi-Cal’s Decision to Cover Whole Genome Sequencing

As of Nov. 1, 2025, Medi-Cal (California’s Medicaid) has begun covering whole genome sequencing (WGS). This landmark coverage expands access to WGS for patients across California.

Ambience Healthcare Launches AI-Powered “Conditions Advisor” to Support Comprehensive Inpatient Documentation and High-Quality Care

Primerdesign Appoints Scientific Laboratory Supplies as Academic UK Distributor

• Offers UK academic research institutions improved access to Primerdesign’s real-time PCR assays and reagents with reliable, fast and local support • SLS to showcase Primerdesign portfolio at Lab Innovations in Birmingham, UK (29–30 October)

EazeBio and UC Santa Cruz Announce Strategic Partnership to Advance Instrument-Free Diagnostic Platform

EazeBio has announced a strategic partnership with the University of California, Santa Cruz to advance and commercialize a groundbreaking instrument-free diagnostic platform.

Spaarne Gasthuis to Advance its Commitment to Patient Care with Proscia’s Software

Spaarne Gasthuis, a top clinical teaching hospital serving part of the Greater Amsterdam region, is fully digitizing its pathology practice with Concentriq® AP-Dx* from Proscia®. With this software platform, the hospital will empower its pathologists to play an even more significant role in guiding personalized treatment decisions for hundreds of thousands of patients each year.

Molsid Announces Successful Completion of Clinical Study for Its First Diagnostic Kit, ResiScreen® Staph, improving antimicrobial resistance detection

Molsid, a French biotech company, announces the successful completion of the clinical performance study for ResiScreen® Staph, an innovantive solution for faster detection of staphylococcal beta-lactamase. Powered by Molsid's patented SmartID® fluorescent biotracer technology, ResiScreen® Staph reaffirms the company's mission to deliver next-generation diagnostic technologies to support clinical laboratories in the contention of antimicrobial resistance.

DNAnexus Honored with Frost & Sullivan’s 2025 Technology Innovation Leadership Award

Recognized for Global Precision Health Informatics Industry Excellence in Best Practices

Syngene International invests in dedicated peptide laboratory and advanced automation

KLAS Emerging Solutions Report: Ambience Healthcare Ranked #1 in Improving Clinician Experience, Top 3 in Both Improving Patient Experience and Improving Outcomes

Creative Diagnostics Launches Validated Inorganic Pyrophosphatase ELISA Kits for mRNA Vaccine Production Quality Control

Creative Diagnostics introduces a comprehensive suite of validated Inorganic Pyrophosphatase ELISA Kits for the research community.

STEMart Launches Advanced Bacterial Reverse Mutation Test (Ames) Service to Accelerate Medical Device Safety Assessment

STEMart announces the launch of its Bacterial Reverse Mutation Test (Ames) service.

eClinical Solutions and ZS Announce Strategic Partnership to Deliver a New Industry Standard for RBQM

Collaboration unites elluminate platform technology and ZS RBQM expertise to offer a fully integrated, data-driven approach to risk and quality management

Proscia to Broaden Pathology AI Capabilities with Biomarker Detection for Skin Tissue

Proscia®, a pathology AI company, will add AI biomarker detection for skin tissue to its Concentriq® software platform, empowering pathologists to drive efficiency and precision. Powered by Primaa, Cleo Skin* will strengthen Concentriq's lead in offering the industry’s broadest portfolio of AI solutions on a single platform.

Baylor Genetics Presents New Data on Clinical and Diagnostic Utility of RNA Sequencing for Rare Disease at the American Society of Human Genetics 2025 Annual Meeting

Baylor Genetics Presents New Data on Clinical and Diagnostic Utility of RNA Sequencing for Rare Disease at the American Society of Human Genetics 2025 Annual Meeting

Scanogen Receives FDA Breakthrough Device Designation for Rapid Bloodstream Infection Assay

Scanogen Inc., a Maryland-based molecular diagnostics company, announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to its rapid assay for bloodstream infection pathogen identification. The company’s SMART platform delivers species-level results in just two hours—compared to several days with current blood culture methods—enabling earlier, targeted antimicrobial therapy that can improve sepsis outcomes and reduce healthcare costs. Supported by multiple NIH research grants, Scanogen is now raising a Series A financing round to fund pivotal clinical studies and bring this transformative technology to market.

Gifthealth is First to Serve 6m Patients Via Direct-to-Patient Platform

Gifthealth, the patient access solution that unifies the prescription journey from provider to patient, today announced it has now served more than six million patients through its direct-to-patient (DTP) platform.

CluePoints’ AI Breakthroughs Earn Dual Recognition at SCDM and SCRIP Awards

CluePoints, provider of leading statistical and AI-driven software solutions, has achieved dual recognition, winning the Clinical Data Science Implementation Excellence Award at the 2025 SCDM Annual Conference and has been named a finalist in the ‘Best Contract Research Organization– Specialist Providers’ category at the 2025 SCRIP Awards.